CO2018002394A2 - Método para la inhibición de la absorción de lípidos y/o la promoción de excreción de lípidos usando d-psicosa - Google Patents
Método para la inhibición de la absorción de lípidos y/o la promoción de excreción de lípidos usando d-psicosaInfo
- Publication number
- CO2018002394A2 CO2018002394A2 CONC2018/0002394A CO2018002394A CO2018002394A2 CO 2018002394 A2 CO2018002394 A2 CO 2018002394A2 CO 2018002394 A CO2018002394 A CO 2018002394A CO 2018002394 A2 CO2018002394 A2 CO 2018002394A2
- Authority
- CO
- Colombia
- Prior art keywords
- psychosa
- lipid
- body fat
- absorption
- prevention
- Prior art date
Links
- 150000002632 lipids Chemical class 0.000 title abstract 8
- 238000010521 absorption reaction Methods 0.000 title abstract 2
- 230000029142 excretion Effects 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 210000000577 adipose tissue Anatomy 0.000 abstract 3
- 230000037396 body weight Effects 0.000 abstract 2
- 208000030159 metabolic disease Diseases 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 210000003608 fece Anatomy 0.000 abstract 1
- 235000013376 functional food Nutrition 0.000 abstract 1
- 235000013402 health food Nutrition 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000000813 small intestine Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
Abstract
La presente invención se relaciona con una composición para la prevención o tratamiento de enfermedades metabólicas relacionadas con lípidos. La composición de acuerdo con la presente invención comprende D-psicosa como ingrediente activo. La D-psicosa tiene la capacidad de inhibir la absorción de lípidos en el intestino delgado y aumentar considerablemente los niveles de lípidos en las heces. Debido a su capacidad, la D-psicosa es efectiva para inhibir la formación de grasa corporal. Además, la D-psicosa reduce el peso corporal, la masa de grasa corporal y los lípidos plasmáticos a niveles normales para normalizar el peso corporal, la masa de grasa corporal y los perfiles de lípidos en plasma. Debido a estas ventajas, se espera que la D-psicosa encuentre aplicación en medicamentos farmacéuticos, alimentos funcionales para la salud y alimentos funcionales adecuados para la prevención y/o tratamiento de enfermedades metabólicas relacionadas con los lípidos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020150123437A KR101692033B1 (ko) | 2015-09-01 | 2015-09-01 | Ｄ-싸이코스를 유효성분으로 함유하는 지질 관련 대사성 질환의 예방 또는 치료용 조성물 |
| PCT/KR2016/009812 WO2017039365A1 (ko) | 2015-09-01 | 2016-09-01 | Ｄ-싸이코스를 이용한 지질 흡수 억제 및/또는 배출 촉진 방법 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2018002394A2 true CO2018002394A2 (es) | 2018-07-19 |
Family
ID=57797262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2018/0002394A CO2018002394A2 (es) | 2015-09-01 | 2018-03-01 | Método para la inhibición de la absorción de lípidos y/o la promoción de excreción de lípidos usando d-psicosa |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20180243325A1 (es) |
| EP (1) | EP3345608B1 (es) |
| JP (1) | JP6619882B2 (es) |
| KR (1) | KR101692033B1 (es) |
| CN (1) | CN107921052A (es) |
| BR (1) | BR112018003842A2 (es) |
| CA (1) | CA2996872A1 (es) |
| CL (1) | CL2018000523A1 (es) |
| CO (1) | CO2018002394A2 (es) |
| MX (1) | MX2018002507A (es) |
| RU (1) | RU2725145C2 (es) |
| UA (1) | UA122342C2 (es) |
| WO (1) | WO2017039365A1 (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102032468B1 (ko) | 2016-10-06 | 2019-10-16 | 씨제이제일제당 (주) | 저장 안정성이 개선된 토마토 케첩 |
| BR112019007024A2 (pt) | 2016-10-07 | 2019-06-25 | Cj Cheiljedang Corp | composição de adoçante com qualidade de sabor melhorada compreendendo alulose e sal e método para melhorar a qualidade do sabor da alulose usando o sal |
| KR102004914B1 (ko) | 2016-10-10 | 2019-07-30 | 씨제이제일제당 (주) | 알룰로스를 포함하는 식물 담금청 및 이의 제조방법 |
| US11812769B2 (en) | 2016-12-21 | 2023-11-14 | Cj Cheiljedang Corporation | Amino acid beverage containing allulose |
| WO2018124704A1 (ko) * | 2016-12-26 | 2018-07-05 | 씨제이제일제당(주) | 알룰로스를 포함하는, 식물성 유지의 생체 외 배출 촉진용 조성물 |
| JP6948671B2 (ja) * | 2017-06-29 | 2021-10-13 | 松谷化学工業株式会社 | Ｄ−ソルボースを有効成分とする糞便脂質排泄促進用組成物 |
| JP6976030B2 (ja) * | 2017-10-27 | 2021-12-01 | サムヤン コーポレイション | 非アルコール性脂肪肝疾患の予防または改善用組成物 |
| JP7216260B2 (ja) * | 2018-11-06 | 2023-02-01 | 株式会社明治 | コプロコッカス属菌の増殖促進用組成物 |
| CN113015533A (zh) * | 2018-11-08 | 2021-06-22 | 国立大学法人香川大学 | 以d-阿洛酮糖为有效成分的褐色脂肪·米色脂肪细胞活化剂 |
| JP7158021B2 (ja) * | 2018-11-29 | 2022-10-21 | 松谷化学工業株式会社 | Ｃｄｃａ増加促進用組成物、ｆｘｒ増加促進用組成物及びｆｘｒ活性化促進用組成物 |
| CN113453755A (zh) * | 2019-02-19 | 2021-09-28 | 国立大学法人香川大学 | 以植物体的形态利用包含生物体内功能成分的日本鼠刺的口服组合物 |
| JP7595271B2 (ja) * | 2019-02-21 | 2024-12-06 | 松谷化学工業株式会社 | 血中ｐｃｓｋ９濃度上昇抑制用組成物 |
| EP3698648A1 (en) * | 2019-02-22 | 2020-08-26 | Pfeifer & Langen GmbH & Co. KG | Allulose pet food |
| KR102460275B1 (ko) * | 2021-03-04 | 2022-10-31 | 경북대학교 산학협력단 | D-리보-2-헥술로스를 유효성분으로 포함하는 사코페니아 예방, 개선 또는 치료용 조성물 |
| KR20240108016A (ko) * | 2022-12-30 | 2024-07-09 | 주식회사 삼양사 | 알룰로스를 이용한 장 질환의 개선 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1757297B1 (en) * | 2004-05-26 | 2013-11-13 | National University Corporation Kagawa University | COMPOSITION FOR treating ARTERIOSCLEROSIS IN DIABETIC PATIENTS |
| JP5645183B2 (ja) * | 2005-07-20 | 2014-12-24 | 帝國製薬株式会社 | Ｄ−プシコースを有効成分として含む肥満状態改善剤 |
| EP2156751B8 (en) * | 2007-05-18 | 2018-11-14 | Matsutani Chemical Industry Co., Ltd. | Novel sweetener having sugar-like taste and production method and use of the same |
| JP5535456B2 (ja) * | 2008-07-09 | 2014-07-02 | 松谷化学工業株式会社 | 食物繊維と希少糖を含む生体機能改善組成物。 |
| MY196089A (en) * | 2013-04-26 | 2023-03-14 | Matsutani Kagaku Kogyo Kk | Agent or Method for Treatment and/or Prevention of Accelerated Energy Expenditure and/or Diminished Energy Expenditure Functionality |
-
2015
- 2015-09-01 KR KR1020150123437A patent/KR101692033B1/ko active Active
-
2016
- 2016-09-01 WO PCT/KR2016/009812 patent/WO2017039365A1/ko not_active Ceased
- 2016-09-01 UA UAA201802536A patent/UA122342C2/uk unknown
- 2016-09-01 EP EP16842331.7A patent/EP3345608B1/en active Active
- 2016-09-01 RU RU2018111327A patent/RU2725145C2/ru active
- 2016-09-01 MX MX2018002507A patent/MX2018002507A/es unknown
- 2016-09-01 CA CA2996872A patent/CA2996872A1/en not_active Abandoned
- 2016-09-01 US US15/756,919 patent/US20180243325A1/en not_active Abandoned
- 2016-09-01 BR BR112018003842-3A patent/BR112018003842A2/pt not_active Application Discontinuation
- 2016-09-01 JP JP2018530463A patent/JP6619882B2/ja active Active
- 2016-09-01 CN CN201680050812.4A patent/CN107921052A/zh active Pending
-
2018
- 2018-02-27 CL CL2018000523A patent/CL2018000523A1/es unknown
- 2018-03-01 CO CONC2018/0002394A patent/CO2018002394A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018530600A (ja) | 2018-10-18 |
| RU2725145C2 (ru) | 2020-06-30 |
| CA2996872A1 (en) | 2017-03-09 |
| EP3345608A4 (en) | 2019-05-01 |
| WO2017039365A1 (ko) | 2017-03-09 |
| RU2018111327A3 (es) | 2019-10-04 |
| BR112018003842A2 (pt) | 2018-09-25 |
| RU2018111327A (ru) | 2019-10-04 |
| US20180243325A1 (en) | 2018-08-30 |
| KR101692033B1 (ko) | 2017-01-03 |
| JP6619882B2 (ja) | 2019-12-11 |
| CN107921052A (zh) | 2018-04-17 |
| EP3345608A1 (en) | 2018-07-11 |
| UA122342C2 (uk) | 2020-10-26 |
| CL2018000523A1 (es) | 2019-02-22 |
| MX2018002507A (es) | 2018-06-11 |
| EP3345608B1 (en) | 2024-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2018002394A2 (es) | Método para la inhibición de la absorción de lípidos y/o la promoción de excreción de lípidos usando d-psicosa | |
| CL2020000747A1 (es) | Formulaciones de niraparib. | |
| CL2013002210A1 (es) | Formulación prebiótica para consumo humano que comprende 2´-fucosilactosa, 3´-sialilactosa y 6´-sialilactosa, en que la cantidad en peso de 3´-sialilactosa es al menos igual de elevada que la cantidad de 2´-fucosilactosa; y método para modular o estimular la proliferación de bifidobacterias en el intestino humano. | |
| MX390627B (es) | Uso de pridopidina para el tratamiento de la disminucion funcional. | |
| MX384234B (es) | Uso de pridopidina para el tratamiento de enfermedad de huntington. | |
| AR093247A1 (es) | Agente profilactico y/o terapeutico para sintomas conductuales y psicologicos asociados con la enfermedad neurodegenerativa o sintomas impulsivos asociados con enfermedad mental que contiene brexpiprazol o sales del mismo | |
| CO6710926A2 (es) | Compuestos de n-heteroarilo | |
| GT201300243A (es) | Derivados de ácido 3-fenilpropiónico ramificados y su uso | |
| BR112015020819A2 (pt) | uso de faecalibacterium prausnitzii htf-f (dsm 26943) para supressão de inflamação | |
| EA201500448A1 (ru) | Гуанидиновое соединение | |
| BR112013010556A2 (pt) | métodos e composições adequadas para a promoção de uma pele saudável | |
| PE20150359A1 (es) | Manejo dietetico de la enfermedad celiaca y alergia alimentaria | |
| BR112015013783A2 (pt) | quitina ou seus derivados para a prevenção e / ou tratamento de parasitoses | |
| TR201821157T4 (tr) | İbandroni̇k asi̇t veya bunun farmasöti̇k olarak kabul edi̇lebi̇li̇r bi̇r tuzu ve d vi̇tami̇ni̇ i̇çeren oral uygulamaya yöneli̇k kati bi̇leşi̇m. | |
| MX2016001635A (es) | Probiotico para el llanto infantil excesivo. | |
| BR112016017765A8 (pt) | composição compreendendo cinamaldeído e zinco, seu uso, e método para produzir um produto alimentício para perda de peso | |
| CO6450623A2 (es) | Parasiticidas sanguineos | |
| CY1117795T1 (el) | Φαρμακευτικες συνθεσεις απαλλαγμενες κιτρικου αλατος οι οποιες περιεχουν ανακινρα | |
| BR112014030288A2 (pt) | composição farmacêutica | |
| CO6602160A2 (es) | Terapia de b12 oral | |
| BR112016012233A8 (pt) | composições compreendendo cinamaldeído, e seus usos | |
| BR112017019364A2 (pt) | dispersões sólidas | |
| BR112016029749A8 (pt) | composição para perda de peso, composição que compreende cinamaldeído e zinco, seus usos, e método para fabricação de umm produto alimentício | |
| BR112012020415A2 (pt) | composição farmacêutica para a prevenção ou tratamento da osteoartrite | |
| WO2016027225A8 (en) | A composition having a muscle-relaxant and anti-inflammatory activity |